- Home
- FBIOP vs RILYP Comparison
FBIOP vs RILYP Comparison
Compare FBIOP & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- RILYP
- Stock Information
- Founded
- FBIOP N/A
- RILYP 1973
- Country
- FBIOP United States
- RILYP United States
- Employees
- FBIOP 101
- RILYP N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- RILYP Investment Managers
- Sector
- FBIOP Health Care
- RILYP Finance
- Exchange
- FBIOP Nasdaq
- RILYP Nasdaq
- Market Cap
- FBIOP N/A
- RILYP N/A
- IPO Year
- FBIOP N/A
- RILYP N/A
- Fundamental
- Price
- FBIOP $6.93
- RILYP $6.36
- Analyst Decision
- FBIOP
- RILYP
- Analyst Count
- FBIOP 0
- RILYP 0
- Target Price
- FBIOP N/A
- RILYP N/A
- AVG Volume (30 Days)
- FBIOP N/A
- RILYP 38.1K
- Earning Date
- FBIOP N/A
- RILYP 01-01-0001
- Dividend Yield
- FBIOP N/A
- RILYP 7.03%
- EPS Growth
- FBIOP N/A
- RILYP N/A
- EPS
- FBIOP N/A
- RILYP N/A
- Revenue
- FBIOP N/A
- RILYP $854,383,000.00
- Revenue This Year
- FBIOP N/A
- RILYP N/A
- Revenue Next Year
- FBIOP N/A
- RILYP N/A
- P/E Ratio
- FBIOP N/A
- RILYP N/A
- Revenue Growth
- FBIOP N/A
- RILYP N/A
- 52 Week Low
- FBIOP N/A
- RILYP $1.73
- 52 Week High
- FBIOP N/A
- RILYP $20.00
- Technical
- Relative Strength Index (RSI)
- FBIOP 36.60
- RILYP 71.70
- Support Level
- FBIOP $6.56
- RILYP $5.71
- Resistance Level
- FBIOP $7.23
- RILYP $6.48
- Average True Range (ATR)
- FBIOP 0.52
- RILYP 0.63
- MACD
- FBIOP -0.09
- RILYP 0.03
- Stochastic Oscillator
- FBIOP 21.08
- RILYP 87.12
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.